The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTEA.L Regulatory News (CTEA)

  • There is currently no data for CTEA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity / PDMR / Exercise of Warrants

15 Sep 2021 07:00

RNS Number : 7626L
Catenae Innovation PLC
15 September 2021
 

 

Catenae Innovation PLC

("Catenae" or the "Company")

 

Issue of Equity / PDMR and Directors' Dealings / Exercise of Warrants

 

Catenae Innovation PLC (AIM: CTEA), the AIM quoted provider of digital media and technology, announces that further to the announcement made on 27 July 2021 the Company has settled certain existing director and PDMR remuneration liabilities through the conversion of accrued salaries and expenses into new ordinary shares (Conversion").

 

Details of the Conversion and Warrant Exercise are set out in the table below.

 

Director

Shareholding prior to Conversion

Liability subject to Conversion

Number of Conversion Shares issued1

Number of shares issued pursuant to Warrant Exercise

Shareholding following Admission

Percentage shareholding following Admission

Guy Meyer2

6,104,582

£20,002.20

1,541,951

2,000,000

9,646,533

3.4%

 

John Farthing

2,741,702

£4,702.14

362,483

-

3,104,185

1.1%

 

 

1 The Conversion Shares are issued at a price of 1.2972p, being the 30 day volume weighted average price per share as at 31 August 2021 ("Conversion Price")

2 As disclosed on 27 July 2021 Guy Meyer intends to transfer £20,000 worth of shares received in lieu of remuneration to an ISA account in his name.

 

Nick Delacamp, the Company's Chief Commercial Officer (non-Board role) received 102,042 shares pursuant to the Conversion which were also issued at the Conversion Price.

 

The Company has received notification from Guy Meyer, a director of the Company, to exercise a warrant (announced 31 January 2020) over 2,000,000 shares at an exercise price of 0.4 pence per share providing the Company with gross proceeds of £8,000 ("Warrant Exercise").

 

Application has been made to the London Stock Exchange for 4,006,476 New Ordinary Shares to be admitted to trading on AIM which is expected to occur on or around 20 September 2021.

 

Total Voting Rights

In conformity with the FCA's Disclosure Guidance and Transparency Rules provision 5.6.1, the Company advises that following the issue of New Ordinary Shares noted above that its issued share capital comprises 281,220,744 Ordinary Shares of 0.2 pence each carrying one vote per share.

Shareholders should use 281,220,744 as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Rules.

- Ends -

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation. The person who arranged for release of this announcement on behalf of the Company was Guy Meyer, Chief Executive Officer of the Company and the Directors of the Company are responsible for the release of this announcement.

 

 

 

For further information please contact:

Catenae Innovation PLC

+44 (0)191 580 8545

Guy Meyer, Chief Executive Officer

 

 

Cairn Financial Advisers LLP (Nominated Adviser)

+44(0)20 7213 0880

Liam Murray / Jo Turner

 

 

 

Brandon Hill Capital Limited, Broker

+44 (0)20 3463 5000

Andy Gutmann

 

 

 

Yellow Jersey PR (PR & IR)

+44 (0)20 3004 9512

Sarah Hollins / Annabel Atkins / Matthew McHale

 

 

Notes to Editors:

About Catenae Innovation PLC

Catenae Innovation is an AIM quoted provider of digital media and technology services. Catenae use the power of blockchain to deliver solutions where its people-centric technology enables trust and certainty allowing organisations to gain better control over their operations, manage staff and safely welcome customers.

www.catenaeinnovation.com

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

(1) Guy Meyer

(2) John Farthing

(3) Nick Delacamp

2

Reason for notification

 

a.

Position/Status

(1) Chief Executive Officer

(2) Chief Financial Officer

(3) Chief Commercial Officer

b.

Initial notification/

Amendment

(1) Initial notification

(2) Initial notification

(3) Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Catenae Innovations PLC

b.

LEI

 

2138007I2D8YWPMSP544

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrumentIdentification Code

Ordinary Shares of 0.2p 

 

ISIN: GB00BKM6CG53

b.

Nature of the transaction

(1) Conversion of liabilities and Exercise of Warrant

(2) Conversion of liabilities

(3) Conversion of liabilities

c.

Price(s) and volume(s)

 

 

 

Price(s) per share

Volume(s)

(1) 1.2972p / 0.4p

(2) 1.2972p

(3) 1.2972p

(1) 1,541,951 / 2,000,000

(2) 362,483

(3) 102,042

 

 

d.

Aggregated information

 

- Aggregated Volume

 

- Price

 

 

N/A

 

N/A

e.

Date of the transaction

13 September 2021

f.

Place of the transaction

AIM, London Stock Exchange

     

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOESFUFLLEFSELU
Date   Source Headline
30th Mar 20213:42 pmRNSDirector dealings
30th Mar 20217:00 amRNSUK Government 'COVID-Status Certification Review'
29th Mar 20217:00 amRNSAnnual Report and Accounts, Trading Update
16th Mar 20211:19 pmRNSExercise of Warrant
16th Mar 20219:05 amRNSSecond Price Monitoring Extn
16th Mar 20219:00 amRNSPrice Monitoring Extension
4th Mar 20217:00 amRNSHolding(s) in Company
3rd Mar 20214:13 pmRNSHolding(s) in Company
26th Feb 202111:00 amRNSCorrection re Placing, Conversions, Warrants
22nd Feb 20214:41 pmRNSSecond Price Monitoring Extn
22nd Feb 20214:35 pmRNSPrice Monitoring Extension
22nd Feb 20217:00 amRNSDigital Identity Policy Consultation
29th Jan 20217:00 amRNSPilot Agreement
27th Jan 20217:00 amRNSPlacing, Conversions, Warrants & Business Update
11th Jan 20212:06 pmRNSSecond Price Monitoring Extn
11th Jan 20212:01 pmRNSPrice Monitoring Extension
18th Dec 202011:39 amRNSHolding(s) in Company
15th Dec 20203:41 pmRNSHolding(s) in Company
15th Dec 20207:00 amRNSBusiness Update
9th Dec 20209:27 amRNSHolding(s) in Company
5th Nov 202012:30 pmRNSUpdate on Afrik-ID
2nd Nov 20202:06 pmRNSSecond Price Monitoring Extn
2nd Nov 20202:01 pmRNSPrice Monitoring Extension
2nd Nov 202011:06 amRNSSecond Price Monitoring Extn
2nd Nov 202011:00 amRNSPrice Monitoring Extension
16th Oct 20208:43 amRNSIssue of Warrants
16th Oct 20207:00 amRNSJoint Venture with Blackhive Africa Medical
25th Sep 202012:26 pmRNSResult of AGM
4th Sep 202012:50 pmRNSPosting of Notice of AGM
27th Aug 20204:41 pmRNSSecond Price Monitoring Extn
27th Aug 20204:35 pmRNSPrice Monitoring Extension
25th Aug 20207:00 amRNSBusiness Update
24th Aug 20207:00 amRNSCreditor Share Conversion and Notice of AGM
19th Aug 20202:32 pmRNSHolding(s) in Company
23rd Jul 202011:05 amRNSSecond Price Monitoring Extn
23rd Jul 202011:00 amRNSPrice Monitoring Extension
20th Jul 20207:00 amRNSChange of Director Role and Grant of Options
17th Jul 20207:00 amRNSTransfer and Exercise of Warrants
9th Jul 202011:05 amRNSSecond Price Monitoring Extn
9th Jul 202011:00 amRNSPrice Monitoring Extension
8th Jul 20209:14 amRNSHolding(s) in Company
6th Jul 20202:06 pmRNSSecond Price Monitoring Extn
6th Jul 20202:00 pmRNSPrice Monitoring Extension
6th Jul 20201:15 pmRNSExercise of Warrants
6th Jul 20207:00 amRNSHolding(s) in Company
3rd Jul 20207:30 amRNSHolding(s) in Company
3rd Jul 20207:00 amRNSCompletion of New Product - Onsite ID
3rd Jul 20207:00 amRNSCommercial Pilot Agreement with Afrik-ID
2nd Jul 20208:01 amRNSHolding(s) in Company
1st Jul 20203:31 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.